{"filing":{"accession_number":"0001171843-26-005289","cik":"0001145986","ticker":"ASPN","company_name":"ASPEN AEROGELS INC","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"f8k_080626.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1145986/000117184326005289/f8k_080626.htm"},"events":[{"id":25471,"run_id":23122,"accession_number":"0001171843-26-005289","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.97,"summary":"Aspen Aerogels announced Q2 2026 financial results on August 6, 2026, reporting total revenue of $49.8 million, net loss of $23.3 million, and adjusted EBITDA of $(6.6) million, along with forward guidance for Q3 2026 revenue of $65–$80 million and adjusted EBITDA of $7–$15 million.","company_name":"ASPEN AEROGELS INC","ticker":"ASPN","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26309,"accession_number":"0001171843-26-005289","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a standard quarterly earnings release for Q2 2026 (ended June 30, 2026) filed on August 6, 2026. The Item 2.02 disclosure announces total revenue of $49.8 million, net loss of $23.3 million, and adjusted EBITDA of $(6.6) million, along with forward guidance for Q3 2026 revenue of $65–$80 million and adjusted EBITDA of $7–$15 million. The press release is attached as Exhibit 99.1 and incorporated by reference, which is the standard structure for earnings releases under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:47:37.759699+00:00","company_name":"","ticker":null,"filing_date":""},{"id":26310,"accession_number":"0001171843-26-005289","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This Item 7.01 disclosure incorporates by reference a press release announcing Aspen Aerogels' second quarter 2026 financial results, including Q2 revenue of $49.8 million, net loss of $23.3 million, and forward-looking guidance for Q3 2026 revenue of $65–$80 million and adjusted EBITDA of $7–$15 million. The disclosure is a standard quarterly earnings announcement with detailed financial performance metrics and business highlights, making it a clear earnings_release event that would materially affect investor assessment of the company's financial condition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:47:37.759699+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26309,"accession_number":"0001171843-26-005289","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"This is a standard quarterly earnings release for Q2 2026 (ended June 30, 2026) filed on August 6, 2026. The Item 2.02 disclosure announces total revenue of $49.8 million, net loss of $23.3 million, and adjusted EBITDA of $(6.6) million, along with forward guidance for Q3 2026 revenue of $65–$80 million and adjusted EBITDA of $7–$15 million. The press release is attached as Exhibit 99.1 and incorporated by reference, which is the standard structure for earnings releases under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:47:37.759699+00:00","company_name":"ASPEN AEROGELS INC","ticker":"ASPN","filing_date":"2026-08-06"},{"id":26310,"accession_number":"0001171843-26-005289","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This Item 7.01 disclosure incorporates by reference a press release announcing Aspen Aerogels' second quarter 2026 financial results, including Q2 revenue of $49.8 million, net loss of $23.3 million, and forward-looking guidance for Q3 2026 revenue of $65–$80 million and adjusted EBITDA of $7–$15 million. The disclosure is a standard quarterly earnings announcement with detailed financial performance metrics and business highlights, making it a clear earnings_release event that would materially affect investor assessment of the company's financial condition.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-08T02:47:37.759699+00:00","company_name":"ASPEN AEROGELS INC","ticker":"ASPN","filing_date":"2026-08-06"}]}